Emissions have plunged 75% since communist times in the birthplace of big oil – but for some the transition has been brutal

A report shows that Africa has emerged as the world's fastest-growing solar market even as global growth slowed last year, driven by a 60% surge in imports of solar panels from China.

Jesus Ochoa and Raymundo Gutierrez are both officers with Customs and Border Protection, ProPublica reports Government documents have identified the two federal officers who fatally shot Alex Pretti in Minneapolis as Jesus Ochoa, a border patrol agent, and Raymundo Gutierrez, an officer with Customs and Border Protection (CBP), according to ProPublica. According to those records, Ochoa, 43, and Gutierrez, 35, were the agents who fired their weapons during the confrontation last weekend that resulted in Pretti’s death. The shooting sparked widespread demonstrations and renewed demands for criminal inquiries into federal immigration enforcement actions. Immediately following Pretti’s killing, the Trump administration repeatedly pushed false claims about the shooting. Continue reading...

The city's mayor Keith Wilson said that it was a “peaceful daytime protest” that “posed no danger to federal forces.”

Grief and aging go hand in hand, but the kind of grief many older adults experience often catches them off guard. Experts offer tools to help them recover.

Revelation that subsidiary of Capgemini is to help trace and expel migrants in US provokes outrage in France French lawmakers have demanded an explanation after one of the country’s biggest tech companies signed a multimillion dollar contract to help the US enforcement agency ICE trace and expel migrants. The revelation that a subsidiary of Capgemini, a multinational digital services firm listed on the Paris stock exchange, had agreed to provide “skip tracing” – a technique for locating targeted people – with big bonuses if successful, has provoked outrage in France. Continue reading...

Reed Jobs, the son of Apple co-founder Steve Jobs, has raised more than $200 million for a venture fund focused on developing new cancer treatments and technologies.